On July 28, 2020, Zenith participated in the Epigenetic Therapeutic Targets Virtual Summit, with an oral presentation by Dr. Eric Campeau, titled: "Design of combination strategies and identification of biomarkers associated with clinical response to ZEN-3694 in combination with enzalutamide in mCRPC."
https://www.zenithepigenetics.com/upload/media_element/122/01/zenith-epigenetic-therapeutic-targets-2020-final.pdf